티앤알바이오팹

246710· KOSDAQ· Health Care· Health Care Equipment & Services

₩2,795+3.33%

2026-08-04

Financials

Valuation Metrics

티앤알바이오팹's Market Cap is ₩1332B. At end of 2025 it was ₩1864B. Ranked #1051 of 2,436 in KR market (top 43%), #534 of 1,649 on KOSDAQ (top 32%), #36 of 96 in Health Care Equipment & Services (top 38%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	133.22B KRW	KR#1,051/2,436 Sec#36/96
Revenue	29.73B KRW	KR#2,033/2,436 Sec#64/96
Net Income	-31.21B KRW	KR—/2,436 Sec—/96
Total Assets	92.17B KRW	KR#1,811/2,436 Sec#55/96
Net Assets	21.42B KRW	KR#2,261/2,436 Sec#86/96
Employees	97	KR#1,647/2,436 Sec#60/96
Value
P/B	6.22x	KR#2,278/2,436 Sec#87/96
P/S	4.48x	KR#2,117/2,436 Sec#70/96
Profitability
ROE	-145.73%	KR#2,362/2,436 Sec#93/96
ROA	-33.86%	KR#2,322/2,436 Sec#90/96
Op. Margin	-21.53%	KR#2,139/2,436 Sec#71/96
Revenue Growth	46.45%	KR#323/2,436 Sec#11/96
Earnings Growth	-703.54%	KR#1,665/2,436 Sec#57/96
Financial Health
Debt Ratio	430.34%	KR#2,272/2,436 Sec#92/96
Total Debt	29.22B KRW	KR#1,206/2,436 Sec#28/96
Cash	7.30B KRW	KR#1,841/2,436 Sec#62/96
Current Ratio	1.03x	KR#1,786/2,436 Sec#81/96
Performance
1Y Return	29.34%	KR#345/2,436 Sec#8/96
1M Return	19.44%	KR#129/2,436 Sec#11/96
From 52W High	-43.25%	KR#910/2,436 Sec#36/96
1Y MDD	-69.44%	KR#1,928/2,436 Sec#70/96
Trading
Volume	422,643 shares	KR#314/2,436 Sec#10/96
Foreign Own.	2.61%	KR#1,046/2,436 Sec#38/96
Per Share
EPS	-819 KRW	KR—/2,436 Sec—/96
BPS	450 KRW	KR#2,397/2,436 Sec#94/96

Company Info

CEO 윤원수

Employees 97

Founded 2013

HQ 경기도 시흥시, KR

Website www.tnrbiofab.com

동사는 2013년 설립, 2018년 코스닥 상장, 2025년 종속회사 블리스팩투자목적회사와 블리스팩 합병 완료함. 조직공학 및 재생의학 기술 기반 3D 바이오프린팅 시스템, 바이오잉크, 생분해성 인공지지체 제조하며 재생의학, 바이오써지컬솔루션, 화장품 사업 영위함. 3D 오가노이드 및 세포치료제 연구개발 중이며 중단기 수익 확보 위해 재생의학 기술 적용한 바이오써지컬 솔루션 사업 전개, 화장품 사업 확장하고 있음. 티앤알바이오팹는 2013년에 설립되었으며 경기도 시흥시에 본사를 두고 있습니다.